tadalafil has been researched along with Complications of Diabetes Mellitus in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bayar, G; Salman, MY; Yavuz, A; Yıldırım, Ç | 1 |
| El Taieb, M; Hegazy, E; Ibrahim, A | 1 |
| Lundberg, GD | 1 |
| Satyanarayana, R; Vickers, MA | 1 |
| Curran, M; Keating, G | 1 |
| Schmitt, H; Schulman, CC; Shen, W; Stothard, DR | 1 |
| Anderson, PC; Arya, M; Gommersall, L; Hayne, D; Patel, HR | 1 |
| Carson, C; Fredlund, P; Kuepfer, C; Murphy, A; Segal, S; Shabsigh, R | 1 |
| Takahashi, Y | 1 |
| Brandetti, F; Carosa, E; Jannini, EA; Lombardo, F; Martini, P | 1 |
| Antonijević, N; Dabetić, M; Dimitrijević-Srecković, V; Dordević, P; Gostiljac, D; Matanović, D; Milić, G; Nale, D; Nisić, T; Popović, S; Vujović, S | 1 |
| Aversa, A; Bruzziches, R; Francomano, D; Greco, EA; Pili, M; Spera, G | 1 |
| Brock, G | 1 |
5 review(s) available for tadalafil and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Tadalafil.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Dose-Response Relationship, Drug; Drug Interactions; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome | 2003 |
New phosphodiesterase inhibitors in the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Diabetes Complications; Drug Interactions; Humans; Imidazoles; Impotence, Vasculogenic; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2004 |
[Erectile dysfunction (ED) and diabetes mellitus].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Diabetic Neuropathies; Diagnosis, Differential; Erectile Dysfunction; Humans; Imidazoles; Male; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2005 |
The therapeutic dilemma: how to use tadalafil.
Topics: Carbolines; Diabetes Complications; Endothelium, Vascular; Erectile Dysfunction; Half-Life; Humans; Male; Nervous System Diseases; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil; Vasodilator Agents | 2005 |
Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of diabetic erectile dysfunction.
Topics: Carbolines; Diabetes Complications; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Retrospective Studies; Safety; Tadalafil; United States; United States Food and Drug Administration | 2008 |
6 trial(s) available for tadalafil and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Comparison of three different tadalafil regimens for erectile dysfunction treatment in patients with diabetes mellitus microvascular complications.
Topics: Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Humans; Male; Reproducibility of Results; Tadalafil; Treatment Outcome | 2022 |
Daily Oral l-Arginine Plus Tadalafil in Diabetic Patients with Erectile Dysfunction: A Double-Blinded, Randomized, Controlled Clinical Trial.
Topics: Adult; Arginine; Diabetes Complications; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Tadalafil; Treatment Outcome | 2019 |
Tadalafil.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Dose-Response Relationship, Drug; Drug Interactions; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Tadalafil; Treatment Outcome | 2003 |
Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Carbolines; Comorbidity; Diabetes Complications; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Patient Satisfaction; Tadalafil; Treatment Outcome | 2004 |
Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
Topics: Aged; Carbolines; Cardiovascular Diseases; Comorbidity; Diabetes Complications; Double-Blind Method; Erectile Dysfunction; Female; Humans; Hyperlipidemias; Male; Middle Aged; Personal Satisfaction; Phosphodiesterase Inhibitors; Postoperative Complications; Prostatectomy; Sexual Partners; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Vasodilator Agents | 2005 |
Effect of tadalafil on erectile dysfunction in male patients with diabetes mellitus.
Topics: Adult; Carbolines; Diabetes Complications; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Tadalafil | 2007 |
3 other study(ies) available for tadalafil and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Daily tadalafil prevents erectile dysfunction in diabetic men.
Topics: Carbolines; Diabetes Complications; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil | 2008 |
Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Clinical Trials, Phase III as Topic; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Erectile Dysfunction; Humans; Imidazoles; Male; Multicenter Studies as Topic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2002 |
Towards optimal ED management: educational forum - II.
Topics: Canada; Carbolines; Diabetes Complications; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride | 2001 |